• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清富含亮氨酸的α-2糖蛋白作为克罗恩病小肠病变生物标志物的最佳应用

Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn's Disease.

作者信息

Asonuma Kunio, Kobayashi Taku, Kikkawa Nao, Nakano Masaru, Sagami Shintaro, Morikubo Hiromu, Miyatani Yusuke, Hojo Aya, Fukuda Tomohiro, Hibi Toshifumi

机构信息

Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.

Department of Gastroenterology and Hepatology, Showa University Fujigaoka Hospital, Yokohama, Japan.

出版信息

Inflamm Intest Dis. 2023 May 11;8(1):13-22. doi: 10.1159/000530825. eCollection 2023 Jan-Dec.

DOI:10.1159/000530825
PMID:37404381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10315012/
Abstract

INTRODUCTION

A large proportion of small bowel lesions in Crohn's disease (CD) may exist beyond the reach of ileocolonoscopy and there is no gold standard imaging modality to screen them, suggesting the need for optimal biomarkers. We aimed to compare the usefulness of C-reactive protein (CRP), faecal calprotectin (FC), and leucine-rich alpha-2 glycoprotein (LRG) in determining small bowel lesions of CD.

METHODS

This was a cross-sectional observational study. CRP, FC, and LRG were prospectively measured in patients with quiescent CD who underwent imaging examinations (capsule or balloon-assisted endoscopy, magnetic resonance enterography, or intestinal ultrasound) selected by the physician in clinical practice. Mucosal healing (MH) of the small bowel was defined as a lack of ulcers. Patients with a CD activity index >150 and active colonic lesions were excluded.

RESULTS

A total of 65 patients (27, MH; 38, small bowel inflammation) were analysed. The area under the curve (AUC) of CRP, FC, and LRG was 0.74 (95% confidence interval: 0.61-0.87), 0.69 (0.52-0.81), and 0.77 (0.59-0.85), respectively. The AUC of FC and LRG in a subgroup of 61 patients with CRP <3 mg/L (26, MH; 32, small bowel inflammation) was 0.68 (0.50-0.81) and 0.74 (0.54-0.84), respectively. The cut-off of 16 μg/mL of LRG showed the highest positive predictive value of 1.00 with specificity of 1.00, while negative predictive value was highest (0.71) with sensitivity of 0.89 at the cut-off of 9 μg/mL.

CONCLUSION

LRG can accurately detect and/or exclude the small bowel lesions with two cut-off values.

摘要

引言

克罗恩病(CD)中很大一部分小肠病变可能存在于回结肠镜检查范围之外,且尚无用于筛查这些病变的金标准成像方式,这表明需要最佳的生物标志物。我们旨在比较C反应蛋白(CRP)、粪便钙卫蛋白(FC)和富含亮氨酸的α-2糖蛋白(LRG)在确定CD小肠病变中的效用。

方法

这是一项横断面观察性研究。对临床实践中由医生选择进行成像检查(胶囊或气囊辅助内镜检查、磁共振肠造影或肠道超声)的静止期CD患者前瞻性地测量CRP、FC和LRG。小肠黏膜愈合(MH)定义为无溃疡。排除CD活动指数>150且有活动性结肠病变的患者。

结果

共分析了65例患者(27例,MH;38例,小肠炎症)。CRP、FC和LRG的曲线下面积(AUC)分别为0.74(95%置信区间:0.61 - 0.87)、0.69(0.52 - 0.81)和0.77(0.59 - 0.85)。在CRP<3mg/L的61例患者亚组(26例,MH;32例,小肠炎症)中,FC和LRG的AUC分别为0.68(0.50 - 0.81)和0.74(0.54 - 0.84)。LRG的截断值为16μg/mL时,阳性预测值最高,为1.00,特异性为1.00;而截断值为9μg/mL时,阴性预测值最高(0.71),敏感性为0.89。

结论

LRG可通过两个截断值准确检测和/或排除小肠病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/a8f39e2c5b69/iid530825_f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/ed856bc9eae9/iid530825_f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/75b4e85a966d/iid530825_f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/03a19f9bf7c6/iid530825_f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/a8f39e2c5b69/iid530825_f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/ed856bc9eae9/iid530825_f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/75b4e85a966d/iid530825_f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/03a19f9bf7c6/iid530825_f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e7/10315012/a8f39e2c5b69/iid530825_f04.jpg

相似文献

1
Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn's Disease.血清富含亮氨酸的α-2糖蛋白作为克罗恩病小肠病变生物标志物的最佳应用
Inflamm Intest Dis. 2023 May 11;8(1):13-22. doi: 10.1159/000530825. eCollection 2023 Jan-Dec.
2
Evaluation of Crohn's Disease Small-Bowel Mucosal Healing Using Capsule Endoscopy and Usefulness of Leucine-Rich α2-Glycoprotein.使用胶囊内镜评估克罗恩病小肠黏膜愈合情况及富含亮氨酸的α2-糖蛋白的效用
Diagnostics (Basel). 2023 Feb 8;13(4):626. doi: 10.3390/diagnostics13040626.
3
Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn's Disease: Is There Any Difference between Small Intestine and Colonic Lesions?血清富含亮氨酸的α2糖蛋白在克罗恩病中的作用:小肠病变与结肠病变之间有差异吗?
Crohns Colitis 360. 2023 May 23;5(3):otad028. doi: 10.1093/crocol/otad028. eCollection 2023 Jul.
4
Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.血清富含亮氨酸的α-2 糖蛋白在评估克罗恩病内镜疾病活动中的准确性。
Inflamm Bowel Dis. 2023 Feb 1;29(2):245-253. doi: 10.1093/ibd/izac076.
5
Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn's Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy.静止期克罗恩病患者血清富含亮氨酸的α-2糖蛋白作为胶囊内镜检测小肠溃疡的潜在替代标志物
J Clin Med. 2022 Apr 29;11(9):2494. doi: 10.3390/jcm11092494.
6
Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.富含亮氨酸的α-2 糖蛋白是评估炎症性肠病临床和内镜疾病活动的可靠血清生物标志物。
Inflamm Bowel Dis. 2023 Sep 1;29(9):1399-1408. doi: 10.1093/ibd/izac230.
7
Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn's disease small bowel lesion in capsule endoscopy.血清富含亮氨酸的α-2糖蛋白在预测克罗恩病小肠病变胶囊内镜检查结果中的效能
Intest Res. 2024 Oct;22(4):464-472. doi: 10.5217/ir.2023.00139. Epub 2024 May 7.
8
Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease.血清富含亮氨酸α-2 糖蛋白可作为预测克罗恩病内镜缓解的指标。
J Gastroenterol Hepatol. 2022 Sep;37(9):1741-1748. doi: 10.1111/jgh.15907. Epub 2022 Jun 10.
9
Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn's Disease.血清富含亮氨酸的α-2糖蛋白作为克罗恩病中小肠黏膜损伤替代标志物的效用
Inflamm Intest Dis. 2023 Jul 10;8(2):69-76. doi: 10.1159/000531622. eCollection 2023 Oct.
10
Leucine-Rich Alpha-2 Glycoprotein in Monitoring Disease Activity and Intestinal Stenosis in Inflammatory Bowel Disease.富含亮氨酸α-2 糖蛋白在炎症性肠病中监测疾病活动和肠狭窄。
Tohoku J Exp Med. 2022 Jul 16;257(4):301-308. doi: 10.1620/tjem.2022.J042. Epub 2022 May 20.

引用本文的文献

1
Complete mucosal healing prevents stricture progression after endoscopic balloon dilation in Crohn's disease.在克罗恩病中,完全黏膜愈合可防止内镜下球囊扩张术后狭窄进展。
DEN Open. 2025 Apr 23;5(1):e70121. doi: 10.1002/deo2.70121. eCollection 2025 Apr.
2
Leucine-rich alpha-2 glycoprotein as a superior biomarker to C-reactive protein for detecting small bowel lesions in Crohn's disease.富含亮氨酸的α-2糖蛋白作为一种比C反应蛋白更优的生物标志物,用于检测克罗恩病中的小肠病变。
World J Gastrointest Endosc. 2025 Feb 16;17(2):100793. doi: 10.4253/wjge.v17.i2.100793.
3
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn's disease: a single-centre, cross-sectional study.

本文引用的文献

1
Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn's Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy.静止期克罗恩病患者血清富含亮氨酸的α-2糖蛋白作为胶囊内镜检测小肠溃疡的潜在替代标志物
J Clin Med. 2022 Apr 29;11(9):2494. doi: 10.3390/jcm11092494.
2
Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.血清富含亮氨酸的α-2 糖蛋白在评估克罗恩病内镜疾病活动中的准确性。
Inflamm Bowel Dis. 2023 Feb 1;29(2):245-253. doi: 10.1093/ibd/izac076.
3
Serum Leucine-Rich α Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn's Disease.
富含亮氨酸的α-2糖蛋白联合C反应蛋白预测克罗恩病的内镜活动度:一项单中心横断面研究
Ann Med. 2025 Dec;57(1):2453083. doi: 10.1080/07853890.2025.2453083. Epub 2025 Jan 17.
4
Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis.血清富含亮氨酸的α2糖蛋白可能是区分结肠黏膜正常患者与炎症性肠病或其他形式结肠炎患者的有用生物标志物。
J Clin Med. 2024 May 17;13(10):2957. doi: 10.3390/jcm13102957.
5
Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn's disease small bowel lesion in capsule endoscopy.血清富含亮氨酸的α-2糖蛋白在预测克罗恩病小肠病变胶囊内镜检查结果中的效能
Intest Res. 2024 Oct;22(4):464-472. doi: 10.5217/ir.2023.00139. Epub 2024 May 7.
血清富含亮氨酸 α-2 糖蛋白:克罗恩病小肠黏膜活性的新型生物标志物。
Clin Gastroenterol Hepatol. 2022 May;20(5):e1196-e1200. doi: 10.1016/j.cgh.2021.06.036. Epub 2021 Jun 30.
4
Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease.富含亮氨酸的α-2 糖蛋白作为炎症性肠病黏膜愈合的标志物。
Sci Rep. 2021 May 27;11(1):11086. doi: 10.1038/s41598-021-90441-x.
5
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.国际共识:炎症性肠病粪便钙卫蛋白检测标准化中的方法学问题。
United European Gastroenterol J. 2021 May;9(4):451-460. doi: 10.1002/ueg2.12069. Epub 2021 May 7.
6
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.STRIDE-II:炎症性肠病(STRIDE)国际研究组织(IOIBD)治疗靶点选择更新:确定炎症性肠病靶向治疗策略的治疗目标。
Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19.
7
Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis.经会阴超声预测溃疡性结肠炎内镜和组织学愈合。
Aliment Pharmacol Ther. 2020 Jun;51(12):1373-1383. doi: 10.1111/apt.15767. Epub 2020 May 7.
8
Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.1 年深度缓解可预防早期克罗恩病进展。
Gastroenterology. 2020 Jul;159(1):139-147. doi: 10.1053/j.gastro.2020.03.039. Epub 2020 Mar 26.
9
Small bowel capsule endoscopy and treat-to-target in Crohn's disease: A systematic review.小肠胶囊内镜检查和针对目标治疗克罗恩病:系统评价。
World J Gastroenterol. 2019 Aug 21;25(31):4534-4554. doi: 10.3748/wjg.v25.i31.4534.
10
Ultrasound vs Endoscopy, Surgery, or Pathology for the Diagnosis of Small Bowel Crohn's Disease and its Complications.超声与内镜、手术或病理学诊断小肠克罗恩病及其并发症的比较。
Inflamm Bowel Dis. 2019 Jul 17;25(8):1313-1338. doi: 10.1093/ibd/izy392.